Biology of clostridium difficile: Implications for epidemiology and diagnosis

Annual Review of Microbiology

Volumn 65, Issue , 2011, Pages 501-521

  Karen C , Carroll ^a   John G , Bartlett ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Hypervirulent; Microbiota; Risk factors; Toxinotypes; Toxins

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; CLOSTRIDIUM DIFFICILE TOXIN A; CLOSTRIDIUM DIFFICILE TOXIN B; LINCOSAMIDE DERIVATIVE; MACROLIDE; PROTON PUMP INHIBITOR; QUINOLINE DERIVED ANTIINFECTIVE AGENT; STREPTOGRAMIN DERIVATIVE; VIRULENCE FACTOR;

ADAPTATION; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL GENOME; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; BACTERIUM IDENTIFICATION; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM DIFFICILE INFECTION; GENE SEQUENCE; HUMAN; INCIDENCE; INFECTION RISK; NONHUMAN; PATHOPHYSIOLOGY; PREVALENCE; PRIORITY JOURNAL; REVIEW; RISK FACTOR;

ANIMALS; BACTERIAL TOXINS; CLOSTRIDIUM DIFFICILE; CLOSTRIDIUM INFECTIONS; GENE EXPRESSION REGULATION, BACTERIAL; HUMANS; VIRULENCE FACTORS;

ANIMALIA; CLOSTRIDIUM DIFFICILE; POSIBACTERIA;

EID: 80053253206     PISSN: 00664227     EISSN: 15453251     Source Type: Book Series    
DOI: 10.1146/annurev-micro-090110-102824     Document Type: Review

References (143)

1. Aichinger E, Schleck CD,HarmsenWS, Nyre LM, Patel R. 2008. Nonutility of repeat laboratory testing for detection of Clostridium difficile by use of PCR or enzyme immunoassay. J. Clin.Microbiol. 46:3795-97
2. Akerlund T, Persson I, Unemo M, Noren T, Svenungsson B, et al. 2008. Increased sporulation rate of epidemic Clostridium difficile type 027/NAP1. J. Clin. Microbiol. 46:1530-33 (Pubitemid 351563610)
3. Aktories K. 2007. Self-cutting to kill: new insights into the processing of Clostridium difficile toxins. ACS Chem. Biol. 2:228-30 (Pubitemid 47629208)
4. al Saif N, Brazier JS. 1996. The distribution of Clostridium difficile in the environment of South Wales. J. Med. Microbiol. 45:133-37 (Pubitemid 26291483)
5. Albesa-JoveD, BertrandT,Carpenter EP, Swain GV, Lim J, et al. 2010. Four distinct structural domains in Clostridium difficile toxin B visualized using SAXS. J. Mol. Biol. 396:1260-70
6. Aronsson B, Möllby R, Nord CE. 1985. Antimicrobial agents and Clostridium difficile in acute enteric disease: epidemiological data from Sweden. J. Infect. Dis. 151:476-81 (Pubitemid 15103799)
7. Arroyo LG, Rousseau J, Willey BM, Low DE, Staempfli H, et al. 2005. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J. Clin.Microbiol. 43: 5341-43 (Pubitemid 41484055)
8. Babady NE, Stiles J, Ruggiero P, Khosa P, Huang D, et al. 2010. Evaluation of the Cepheid Xpert Clostridium difficile EPI assay for diagnosis of Clostridium difficile infection and typing of the NAP1 strain at a cancer hospital. J. Clin. Microbiol. 48:4519-24
9. Barbut F, Braun M, Burghoffer B, Lalande V, Eckert C. 2009. Rapid detection of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J. Clin. Microbiol. 47:1276-77
10. Barbut F, Petit JC. 2001. Epidemiology of Clostridium difficile-associated infections. Clin. Microbiol. Infect. 7:405-10 (Pubitemid 34960330)
11. Barc MC, Bourlioux F, Janoir C, Charrin-Sarnel C, Janoir C, et al. 2004. Effect of amoxicillin-clavulanate on human fecal flora in a gnotobiotic mouse model measured with group specific 16SrRNA targeted oligonucleotide probes in combination with flow cytometry. Antimicrob. Agents Chemother. 48:1365-68 (Pubitemid 38405497)
12. Barth H, Pfeifer G, Hofmann F,Maier E, Benz R, Aktories K. 2001. Low pH-induced formation of ion channels by Clostridium difficile toxin B in target cells. J. Biol. Chem. 276:10670-76 (Pubitemid 38089237)
13. Bartlett JG. 1994. Clostridium difficile: history of its role as an enteric pathogen and the current state of knowledge about the organism. Clin. Infect. Dis. 18(Suppl. 4):S265-72 (Pubitemid 24148653)
14. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. 1978. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N. Engl. J. Med. 298:531-34 (Pubitemid 8295586)
15. Bartlett JG. 1980. Experimental studies of antibiotic associated colitis. Scand. J. Infect. Dis. (Suppl. 22):11-15 (Pubitemid 11200184)
16. Bartlett JG, ChangTW,OnderdonkAB. 1978. Will the real Clostridium species responsible for antibioticassociated colitis please step forward? Lancet 1:338 (Pubitemid 8273587)
17. Bartlett JG, Moon N, Chang TW, Taylor N, Onderdonk AB. 1978. Role of Clostridium difficile in antibiotic-associated pseudomembranous colitis. Gastroenterology 75:778-82 (Pubitemid 9040959)
18. Bartlett JG, Onderdonk AB, Cisneros RL. 1977. Clindamycin-associated colitis in hamsters: protection with vancomycin. Gastroenterology 73:772-76 (Pubitemid 8210076)
19. Bartlett JG, Onderdonk AB, Cisneros RL, Kasper DL. 1977. Clindamycin-associated colitis due to a toxin-producing species of Clostridium in hamsters. J. Infect. Dis. 136:701-5 (Pubitemid 8223685)
20. Bauer MP, Notermans DW, Van Benthem BH, Brazier JS, Wilcox MH, et al. 2011. Clostridium difficile infection in Europe: a hospital-based survey. Lancet 377:63-73
21. Bäverud V. 2002. Clostridium difficile infections in animals with special reference to the horse. A review. Vet. Q. 24:203-19 (Pubitemid 36109126)
22. Best EL, Fawley WN, Parnell P, Wilcox MH. 2010. The potential for airborne dispersal of Clostridium difficile from symptomatic patients. Clin. Infect. Dis. 50:1450-57
23. Bliss DZ, Johnson S, Clabots CR, Savik K, Gerding DN. 1997. Comparison of cycloserine-cefoxitinfructose agar (CCFA) and taurocholate-CCFA for recovery of Clostridium difficile during surveillance of hospitalized patients. Diagn. Microbiol. Infect. Dis. 29:1-4 (Pubitemid 27472913)
24. Borek AP, Aird DZ, Carroll KC. 2005. Frequency of sample submission for optimal utilization of the cell culture cytotoxicity assay for detection of Clostridium difficile toxin. J. Clin. Microbiol. 43:2994-95 (Pubitemid 40827997)
25. Bouza E, Pelaez, T, Alonso R, Catalan P, Munoz P, Creixems MR. 2001. 'Second-look? cytotoxicity: an evaluation of culture plus cytotoxin assay of Clostridium difficile isolates in the laboratory diagnosis of CDAD. J. Hosp. Infect. 48:233-37 (Pubitemid 32680863)
26. Calabi E, Ward S, Wren B, Paxton T, Panico M, et al. Molecular characterization of the surface layer proteins from Clostridium difficile. Mol. Microbiol. 40:1187-99
27. Cardona DM, Rand KH. 2008. Evaluation of repeat Clostridium difficile enzyme immunoassay testing. J. Clin. Microbiol. 46:3686-89
28. Clabots CR, Gerding SJ, Olson MM, Peterson LR, Gerding DN. 1989. Detection of asymptomatic Clostridium difficile carriage by an alcohol shock procedure. J. Clin. Microbiol. 27:2386-87 (Pubitemid 19240636)
29. Clements AC,Magalhães RJ, Tatem AJ, Paterson DL, Riley TV. 2010. Clostridium difficile PCR ribotype 027: assessing the risks of further worldwide spread. Lancet Infect. Dis. 10:395-404
30. Cohen SH, Tang YJ, Silva J Jr. 2000. Analysis of the pathogenicity locus in Clostridium difficile strains. J. Infect. Dis. 181:659-63 (Pubitemid 30131836)
31. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, et al. 2010. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the infectious diseases society of America. Infect. Control Hosp. Epidemiol. 31:431-55
32. Collignon A. 2010. Methods for working with the mouse model. In Clostridium difficile: Methods in Molecular Biology, ed. P Mullany, AP Roberts, pp. 229-37. New York: Springer. 646 pp.
33. Crobach MJT, Dekkers OM,WilcoxMH, Kuijper EJ. 2009. European Society of Clinical Microbiology and Infectious Diseases (ESCMID): data review and recommendations for diagnosing Clostridium difficileinfection (CDI). Clin. Microbiol. Infect. 15:1053-66
34. Curry SR, Marsh JW, Muto CA, O'Leary MM, Pasculle AW, Harrison LH. 2007. tcdC genotypes associated with severe TcdC truncation in an epidemic clone and other strains of Clostridium difficile. J. Clin. Microbiol. 45:215-21 (Pubitemid 46106429)
35. Curry S. 2010. Clostridium difficile. Clin. Lab. Med. 30:329-42
36. Dawson LF, Valiente E, Wren BW. 2009. Clostridium difficile-a continually evolving and problematic pathogen. Infect. Genet. Evol. 9:1410-17
37. De Somer P, Van de Voorde H, Eyssen H, Van Dijck P. 1955. A study on penicillin toxicity in guinea pigs. Antibiot. Chemother. 5:463-69
38. Debast SB, Vaessen N, Choudry A, Wiegeers-Ligtvoet EA, van den Berg RJ, et al. 2009. Successful combat of an outbreak due to Clostridium difficile PCR ribotype 027 and recognition of specific risk factors. Clin. Microbiol. Infect. 15:427-34
39. Delmée M, Verellen G, Avesani V, Francois G. 1988. Clostridium difficile in neonates: serogrouping and epidemiology. Eur. J. Pediatr. 147:36-40 (Pubitemid 18027558)
40. Deneve C, Janoir C, Poilane I, Fantinato C, Collignon A. 2009. New trends in Clostridium difficile virulence and pathogenesis. Intern. J. Antimicrob. Agents 33:S24-28
41. Dial S, Delaney JA, Barkun AN, Suissa S. 2005. Use of gastric acid-suppressive agents and risk of community-acquired Clostridium difficile-associated disease. JAMA 294:2989-95 (Pubitemid 41817660)
42. Dineen SS, Villapakkam AC, Nordman JT, Sonenshein AL. 2007. Repression of Clostridium difficile toxin gene expression by CodY. Mol. Microbiol. 66:206-19 (Pubitemid 47414797)
43. Doing KM, Hintz MS, Keefe C, Horne S, LeVasseur S, Kulikowski ML. 2010. Reevaluation of the Premier Clostridium difficile toxin A and B immunoassay with comparison to glutamate dehydrogenase common antigen testing evaluating Bartels cytotoxin and Prodesse ProGastro Cd polymerase chain reaction as confirmatory procedures. Diagn. Microbiol. Infect. Dis. 66:129-34
44. Donskey CJ. 2010. Preventing transmission of Clostridium difficile: Is the answer blowing in the wind? Clin. Infect. Dis. 50:1458-61
45. Drudy D, Calabi E, Kyne L, Sougioultzis S, Kelly E, et al. 2004. Human antibody response to surface layer proteins in Clostridium difficile infection. FEMS Immunol. Med. Microbiol. 41:237-42 (Pubitemid 38757871)
46. Drudy D, Fanning S, Kyne L. 2007. Toxin A-negative, toxin B-positive Clostridium difficile. Int. J. Infect. Dis. 11:5-10 (Pubitemid 44937660)
47. Dubberke ER, Butler AM, Yokoe DS, Mayer J, Hota B, et al. 2010. Multicenter study of Clostridium difficile infection rates from 2000 to 2006. Infect. Control Hosp. Epidemiol. 31:1030-37
48. Dupuy B, Govind R, Antunes A, Matamouros S. 2008. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J. Med. Microbiol. 57:685-89 (Pubitemid 351842058)
49. Eastwood K, Else P, Charlett A, WilcoxM. 2009. Comparison of nine commercially available Clostridium difficile toxin detection assays, a real-time PCR assay for C. difficile tcdB, and a glutamate dehydrogenase detection assay to cytotoxin testing and cytotoxigenic culture methods. J. Clin. Microbiol. 47:3211-17
50. Fagan RP, Albesa-Jové D, Qazi O, Svergun DI, Brown KA, Fairweather NF. 2009. Structural insights into the molecular organization of the S-layer from Clostridium difficile. Mol. Microbiol. 71:1308-22
51. Fenner L, Widmer AF, Goy G, Rudin S, Frei R. 2008. Rapid and reliable diagnostic algorithm for detection of Clostridium difficile. J. Clin. Microbiol. 46:328-30
52. Freeman J, BauerMP, Baines SD, Corver J, FawleyWN, et al. 2010. The changing epidemiology of Clostridium difficile infections. Clin. Microbiol. Rev. 23:529-49
53. George WL, Sutter VL, Citron D, Finegold SM. 1979. Selective and differential medium for isolation of Clostridium difficile. J. Clin. Microbiol. 9:214-19 (Pubitemid 9123787)
54. George RH, Symonds JM, Dimock F, Brown JD, Arabi Y, et al. 1978. Identification of Clostridium difficile as a cause of pseudomembranous colitis. Br. Med J. 1:695 (Pubitemid 8318970)
55. Gerding DN. 2004. Clindamycin, cephalosporins, fluoroquinolones, and Clostridium difficile-associated diarrhea: This is an antimicrobial resistance problem. Clin. Infect. Dis. 38:646-48 (Pubitemid 38333859)
56. Gerding DN. 2010. Global epidemiology of Clostridium difficile infection in 2010. Infect. Control Hosp. Epidemiol. 31(Suppl. 1):S32-34
57. Geric B, Carman RJ, Rupnik M, Genheimer CW, Sambol SP, et al. 2006. Binary toxin-producing large clostridial toxin-negative Clostridium difficile strains are enterotoxic but do not cause disease in hamsters. J. Infect. Dis. 193:1143-50
58. Giesemann T, Egerer M, Jank T, Aktories K. 2008. Processing of Clostridium difficile toxins. J. Med. Microbiol. 57:690-96 (Pubitemid 351842059)
59. Goldenberg SD, Dieringer T, French GL. 2010. Detection of toxigenic Clostridium difficile in diarrheal stools by real-time polymerase chain reaction. Diagn. Microbiol. Infect. Dis. 67:304-7
60. Goorhuis A, Bakker D, Corver J, Debast, Harmanus C, et al. 2008. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin. Infect. Dis. 47:1162-70
61. Gould LH, Limbago B. 2010. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin. Infect. Dis. 51:577-82
62. Green RH. 1974. The association of viral activation with penicillin toxicity in guinea pigs and hamsters. Yale J. Biol. Med. 47:166-81
63. Hall IC, O'Toole E. 1935. Intestinal flora in newborn infants: with a description of a new pathogenic anaerobe, Bacillus difficilis. Am. J. Dis. Child. 49:390
64. Hambre DM, Rake G, McKee CM, MacPhillamy HB. 1943. The toxicity of penicillin as prepared for clinical use. Am. J. Med. Sci. 206:642
65. Hanff PA, Zaleznik DF, Kent KC, Rubin MS, Kelly E, et al. 1993. Use of heat shock for culturing Clostridium difficile from rectal swabs. Clin. Infect. Dis. 16(Suppl. 14):S245-47 (Pubitemid 23157922)
66. Heap JT, Pennington OJ, Cartman ST, Carter GP,Minton NP. 2007. The ClosTron: a universal gene knock-out system for the genus Clostridium. J. Microbiol. Methods 70:452-64 (Pubitemid 47302149)
67. Huang H, Weintraub A, Fang H, Nord CE. 2009. Comparison of a commercial multiplex real-time PCR to the cell cytotoxicity neutralization assay for diagnosis of Clostridium difficile infections. J. Clin. Microbiol. 47:3729-31
68. Jank T, Aktories K. 2008. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol. 16:222-29
69. Kallen AJ, Thompson A, Ristaino P, Chapman L, Nicholson A, et al. 2009. Complete restriction of fluoroquinolone use to control an outbreak of Clostridium difficile infection at a community hospital. Infect. Control Hosp. Epidemiol. 30:264-72
70. Karre T, Sloan L, Patel R, Mandrekar J, Rosenblatt J. 2011. Comparison of two commercial molecular assays to a laboratory-developed molecular assay for diagnosis of Clostridium difficile infection. J. Clin. Microbiol. 49:725-27
71. Khan MY, Hall WH. 1966. Staphylococcal enterocolitis: treatment with oral vancomycin. Ann. Intern. Med. 65:1-8
72. Kim KH, Fekety R, Batts DH, Brown D, Cudmore M, et al. 1981. Isolation of Clostridium difficile from the environment and contacts of patients with antibiotic-associated colitis. J. Infect. Dis. 143:42-50 (Pubitemid 11152596)
73. Knetsch CW, Bakker D, de Boer RF, Sanders I, Hofs S, et al. 2011. Comparison of real-time PCR techniques to cytogenic culture methods for diagnosing Clostridium difficile infection. J. Clin. Microbiol. 49:227-31
74. Kuehne SA, Cartman ST, Heap JT, Kelly ML, Cockayne A,Minton NP. 2009. The role of toxin A and toxin B in Clostridium difficile infection. Nature 467:711-14
75. Kuijper EJ, van den Berg RJ,Debast S, Visser CE, Veenendaal P, et al. 2006. Clostridium difficile ribotype 027, toxinotype III, The Netherlands. Emerg. Infect. Dis. 12:827-30 (Pubitemid 43726862)
76. Kvach EJ, Ferguson D, Riska PF, Landry ML. 2010. Comparison of BD GeneOhm Cdiff real-time PCR assay with a two-step algorithm and a toxin A/B enzyme-linked immunosorbent assay for diagnosis of toxigenic Clostridium difficile infection. J. Clin. Microbiol. 48:109-14
77. Kyne L. 2010. Clostridium difficile-beyond antibiotics. N. Engl. J. Med. 362:264-65
78. Lahn M, Tyler G, Daubener W, Hadding U. 1993. Improvement of Clostridium difficile isolation by heat-shock and typing of the isolated strains by SDS-PAGE. Eur. J. Epidemiol. 9:327-34 (Pubitemid 23238062)
79. Larson AM, Fung AM, Fang FC. 2010. Evaluation of tcdB real-time PCR in a three-step diagnostic algorithm for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 48:124-30
80. Lawley TD, Croucher NJ, Yu L, Clare S, Sebaihia M, et al. 2009. Proteomic and genomic characterization of highly infectious Clostridium difficile 630 spores. J. Bacteriol. 191:5377-86
81. Leonard J, Marshall JK, Moayyedi P. 2007. Systematic review of the risk of enteric infection in patients taking acid suppression. Am. J. Gastroenterol. 102:2047-56 (Pubitemid 47301504)
82. Levett PN. 1986. Clostridium difficile in habitats other than the human gastrointestinal tract. J. Infect. 12:253-63 (Pubitemid 16116750)
83. Linsky A, Gupta K, Lawler EV, Fonda JR, Hermos JA. 2010. Proton pump inhibitors and risk for recurrent Clostridium difficile infection. Arch. Intern. Med. 170:772-78
84. Loo VG, Poirier L, Miller MA, Oughton M, Libman MD, et al. 2005. A predominantly clonal multiinstitutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality. N. Engl. J. Med. 353:2442-49 (Pubitemid 41770165)
85. Loo VG, Libman MD, Miller MA, Bourgault AM, Frenette CH, et al. 2004. Clostridium difficile: a formidable foe. Can. Med. Assoc. J. 171:47-48 (Pubitemid 38925119)
86. Lowy I, Molrine DC, Leav BA, Blair BM, Baxter R, et al. 2010. Treatment with monoclonal antibodies against Clostridium difficile toxins. N. Engl. J. Med. 362:197-205
87. Luo RF, Banaei N. 2010. Is repeat PCR needed for diagnosis of Clostridium difficile infection? J. Clin. Microbiol. 48:3738-41
88. Lyras D, O'Connor JR, Howarth PM, Sambol SP, Carter GP, et al. 2009. Toxin B is essential for virulence of Clostridium difficile. Nature 458:1176-79
89. Marler LM, Siders JA, Wolters LC, Pettigrew Y, Skitt BL, Allen SD. 1992. Comparison of five cultural procedures for isolation of Clostridium difficile from stools. J. Clin. Microbiol. 30:514-16
90. Matamouros S, England P, Dupuy B. 2007. Clostridium difficile toxin expression is inhibited by the novel regulator TcdC. Mol. Microbiol. 64:1274-88 (Pubitemid 46849018)
91. McDonald LC, Kilgore GE, Thompson A, Owens RC Jr, Kazakova SV, et al. 2005. An epidemic, toxin gene-variant strain of Clostridium difficile. N. Engl. J. Med. 353:2433-41 (Pubitemid 41770164)
92. McFarland LV, Mulligan ME, Kwok RY, Stamm WE. 1989. Nosocomial acquisition of Clostridium difficile infection. N. Engl. J. Med. 320:204-10 (Pubitemid 19034145)
93. Morgan OW, Rodrigues B, ElstonT, VerlanderNQ, BrownDF, et al. 2008. Clinical severity of Clostridium difficile PCR ribotype 027: a case-case study. PLoS One 3:e1812
94. Mundy LS, Shanholtzer CJ, Willard KE, Gerding DN, Peterson LR. 1995. Laboratory detection of Clostridium difficile. A comparison of media and incubation systems. Am. J. Clin. Pathol. 103:52-56
95. Murray R, Boyd D, Levett PN, Mulvey MR, AlfaMJ. 2009. Truncation in the tcdC region of Clostridium difficile PathLoc of clinical isolates does not predict increased biological activity of Toxin B or Toxin A. BMC Infect. Dis. 9:103
96. Muto CA, PokrywkaM, Shutt K, Mendelsohn AB, Nouri K, et al. 2005. A large outbreak of Clostridium difficile-associated disease with an unexpected proportion of deaths and colectomies at a teaching hospital following increased fluoroquinolone use. Infect. Control Hosp. Epidemiol. 26:273-80 (Pubitemid 40445086)
97. Nemat H, Khan R, Ashraf MS, Matta M, Ahmed S, et al. 2009. Diagnostic value of repeated enzyme immunoassays in Clostridium difficile infection. Am. J. Gastroenterol. 104:2035-41
98. Norén T, Alriksson I, Andersson J, Akerlund T, Unemo M. 2011. Rapid and sensitive loop-mediated isothermal amplification test for Clostridium difficile detection challenges cytotoxin B cell test and culture as gold standard. J. Clin. Microbiol. 49:710-11
99. Novak-Weekley SM, Marlowe EM, Miller JM, Cumpio J, Nomura JH, et al. 2010. Clostridium difficile testing in the clinical laboratory by use of multiple testing algorithms. J. Clin. Microbiol. 48:889-93
100. O'Connor JR, Johnson S, Gerding DN. 2009. Clostridium difficile infection caused by the epidemic BI/BNAP1/027 strain. Gastroenterology 136:1913-24
101. Panessa-Warren BJ, Tortora GT, Warren JB. 2007. High resolution FESEM and TEM reveal bacterial spore attachment. Microsc. Microanal. 13:251-66 (Pubitemid 47117321)
102. Pépin J, Valiquette L, Alary ME, Villemure P, Pelletier A, et al. 2004. Clostridium difficile- associated diarrhea in a region of Quebec from 1991 to 2003: a changing pattern of disease severity. Can. Med. Assoc. J. 171:466-72 (Pubitemid 39179608)
103. Pépin J, Valiquette L, Cossette B. 2005. Mortality attributable to nosocomial Clostridium difficile- associated disease during an epidemic caused by a hypervirulent strain in Quebec. Can. Med. Assoc. J. 173:1037-42
104. Peterson LR, Kelly PJ, Nordbrock HA. 1996. Role of culture and toxin detection in laboratory testing for diagnosis of Clostridium difficile-associated diarrhea. Eur. J. Clin. Microbiol. Infect. Dis. 15:330-36 (Pubitemid 26159696)
105. Peterson LR, Manson RU, Paule SM, Hacek DM, Robicsek A, et al. 2007. Detection of toxigenic Clostridium difficile in stool samples by real-time polymerase chain reaction for the diagnosis of C. difficile- associated diarrhea. Clin. Infect. Dis. 45:1152-60 (Pubitemid 47580313)
106. Peterson LR, Robicsek A. 2009. Does my patient have Clostridium difficile infection? Ann. Int. Med. 151:176-79
107. Planche T, Aghaizu A, Holliman R, Riley P, Poloniecki J, et al. 2008. Diagnosis of Clostridium difficile infection by toxin detection kits: a systematic review. Lancet Infect. Dis. 8:777-84
108. Qa'DanM,SpyresLM,Ballard JD. 2000. pH-enhanced cytopathic conformational changes in Clostridium difficile toxin B. Infect. Immun. 68:2470-74 (Pubitemid 30253815)
109. Quinn CD, Sefers SE, Babiker W, He Y, Alcabasa R, et al. 2010. C. Diff Quik Chek complete enzyme immunoassay provides a reliable first-line method for detection of Clostridium difficile in stool specimens. J. Clin. Microbiol. 48:603-5
110. Redelings MD, Sorvillo F, Mascola L. 2007. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg. Infect. Dis. 13:1417-19 (Pubitemid 47510317)
111. Reineke J, Tenzer S, Rupnik M, Koschinski A, Hasselmayer O, et al. 2007. Autocatalytic cleavage of Clostridium difficile toxin B. Nature 446:415-19 (Pubitemid 46474600)
112. Reller ME, Lema CA, Perl TM, Cai M, Ross TL, et al. 2007. Yield of stool culture with isolate toxin testing versus a two-step algorithm including stool toxin testing for detection of toxigenic Clostridium difficile. J. Clin. Microbiol. 45:3601-5 (Pubitemid 350156855)
113. Ricciardi R, Rothenberger DA, Madoff RD, Baxter NN. 2007. Increasing prevalence and severity of Clostridium difficile colitis in hospitalized patients in the United States. Arch. Surg. 142:624-31 (Pubitemid 47080440)
114. Rupnik M, Avesani V, Janc M, von Eichel-Streiber C, Delmee M. 1998. A novel toxinotyping scheme and correlation of toxinotypes with serogroups of Clostridium difficile isolates. J. Clin.Microbiol. 36:2240-47 (Pubitemid 28324074)
115. Rupnik M, Pabst S, Rupnik M, von Eichel-Streiber C, Urlaub H, Söling HD. 2005. Characterization of the cleavage site and function of resulting cleavage fragments after limited proteolysis of Clostridium difficile toxin B (TcdB) by host cells. Microbiology 151:199-208 (Pubitemid 40214335)
116. Rupnik M, Wilcox MH, Gerding DN. 2009. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat. Rev. Microbiol. 7:526-36
117. Rupnik M. 2010. Clostridium difficile: (re)emergence of zoonotic potential. Clin. Infect. Dis. 51:583-84
118. Saxton K, Baines SD, Freeman J, O'Connor R,WilcoxMH. 2009. Effects of exposure of Clostridium difficile PCR ribotypes 027 and 001 to fluoroquinolones in a human gut model. Antimicrob. Agents Chemother. 53:412-20
119. Schirmer J, Aktories K. 2004. Large clostridial cytotoxins: cellular biology of Rho/Ras-glucosylating toxins. Biochim. Biophys. Acta 1673:66-74 (Pubitemid 38844795)
120. Schwan C, Stecher B, Tzivelekidis T, van Hamm M, Rohde M, et al. 2009. Clostridium difficile toxin CDT induces formation of microtubule-based protrusions and increases adherence of bacteria. PLoS Pathog. 5:1-14
121. Sebaihia M, Wren BW, Mullany P, Fairweather NF, Minton N, et al. 2006. The multi-drug resistant human pathogen Clostridium difficile has a highly mobile, mosaic genome. Nat. Genet. 38:779-86 (Pubitemid 43980598)
122. Sharp SE, Ruden LO, Pohl JC, Hatcher PA, Jayne LM, IvieWM. 2010. Evaluation of the C. Diff Quik Chek Complete Assay, a new glutamate dehydrogenase and A/B toxin combination lateral flow assay for use in rapid, simple diagnosis of Clostridium difficile disease. J. Clin. Microbiol. 48:2082-86
123. Shetty N, Wren MWD, Coen PG. 2011. The role of glutamate dehydrogenase for the detection of Clostridium difficile in faecal samples: a meta-analysis. J. Hosp. Infect. 77:1-6
124. Snell H, RamosM, Longo S, John M, Hussain Z. 2004. Performance of the TechLabCDIFFCHEK-60 enzyme immunoassay (EIA) in combination with the C. difficile Tox A/B II EIA kit, the Triage C. difficile panel immunoassay, and a cytotoxin assay for diagnosis of Clostridium difficile-associated diarrhea. J. Clin. Microbiol. 42:4863-65 (Pubitemid 39362426)
125. Snyder MD. 1937. Further studies on Bacillus difficilis. J. Infect. Dis. 60:223
126. Spigaglia P, Mastrantonio P. 2002. Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates. J. Clin. Microbiol. 40:3470-75 (Pubitemid 34977470)
127. Stabler RA, Gerding DN, Songer JG, Drudy D, Brazier JS, et al. 2006. Comparative phylogenomics of Clostridium difficile reveals clade specificity and microevolution of hypervirulent strains. J. Bacteriol. 188:7297-305 (Pubitemid 44547635)
128. Stamper PD, Alcabasa A, Aird D, Babiker W, Wehrlin J, et al. 2009. Comparison of a commercial realtime PCR assay for tcdB detection to a cell culture cytotoxicity assay and toxigenic culture for direct detection of toxin-producing Clostridium difficile in clinical samples. J. Clin. Microbiol. 47:373-78
129. Stamper PD, Babiker W, Alcabasa R, Aird D, Wehrlin J, et al. 2009. Evaluation of a new commercial TaqMan PCR assay for direct detection of the Clostridium difficile toxin B gene in clinical stool specimens. J. Clin. Microbiol. 47:3846-50
130. Sundriyal A, Roberts AK, Ling R, McGlashan J, Shone CC, Acharya KR. 2010. Expression, purification and cell cytotoxicity of actin-modifying binary toxin from Clostridium difficile. Protein Exp. Purif. 74:42-48
131. Swindells J, Brenwald N, Reading N, Oppenheim B. 2010. Evaluation of diagnostic tests for Clostridium difficile infection. J. Clin. Microbiol. 48:606-8
132. Tedesco FJ, Barton RW, Alpers DH. 1974. Clindamycin-associated colitis: a prospective study. Ann. Intern. Med. 81:429-33
133. Tenover FC, Novak-Weekley S,Woods CW, Peterson LR, DavisT, et al. 2010. Impact of strain type on detection of toxigenic Clostridium difficile: comparison of molecular diagnostic and enzyme immunoassay approaches. J. Clin. Microbiol. 48:3719-24
134. Terhes G, Urbán E, Sóki J, Nacsa E, Nagy E. 2009. Comparison of a rapid molecular method, the BD GeneOhm Cdiff assay, to the most frequently used laboratory tests for detection of toxin-producing Clostridium difficile in diarrheal feces. J. Clin. Microbiol. 47:3478-81
135. Ticehurst JR, Aird DZ, Dam LM, Borek AP, Hargrove JT, Carroll KC. 2006. Effective detection of toxigenic Clostridium difficile by a two-step algorithm including tests for antigen and cytotoxin. J. Clin. Microbiol. 44:1145-49
136. Torres JF, Cedillo R, Sánchez J, Dillman C, Giono S,Muñoz O. 1984. Prevalence of Clostridium difficile and its cytotoxin in infants in Mexico. J. Clin. Microbiol. 20:274-75 (Pubitemid 15189429)
137. Underwood S, Guan S, Vijayasubhash V, Baines SD, Graham L, et al. 2009. Characterization of the sporulation initiation pathway of Clostridium difficile and its role in toxin production. J. Bacteriol. 191:7296-305
138. Voth DE, Ballard JD. 2005. Clostridium difficile toxins: mechanism of action and role in disease. Clin. Microbiol. Rev. 18:247-63 (Pubitemid 40548293)
139. Warny M, Pepin J, Fang A, Killgore G, Thompson A, et al. 2005. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 366:1079-84 (Pubitemid 41338761)
140. Weese JS, Avery BP, Rousseau J, Reid-Smith RJ. 2009. Detection and enumeration of Clostridium difficile spores in retail beef and pork. Appl. Environ. Microbiol. 75:5009-11
141. Weese JS, Finley R, Reid-Smith RR, JaneckoW, Rousseau J. 2010. Evaluation of Clostridium difficile in dogs and the household environment. Epidemiol. Infect. 138:1100-4
142. Zheng L, Keller SF, Lyerly DM, Carman RJ, Genheimer CW, et al. 2004. Multicenter evaluation of a new screening test that detects Clostridium difficile in fecal specimens. J. Clin. Microbiol. 42:3837-40 (Pubitemid 39045725)
143. Zilberberg MD. 2009. Clostridium difficile-related hospitalization among US adults, 2006. Emerg. Infect. Dis. 15:122-24